INNMF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
16.62M
IVEVF
Price
$2.28
Change
-$1.36 (-37.36%)
Updated
Feb 12 closing price
Capitalization
460.67M
Interact to see
Advertisement

INNMF vs IVEVF

Header iconINNMF vs IVEVF Comparison
Open Charts INNMF vs IVEVFBanner chart's image
Amplia Therapeutics
Price$0.04
Change-$0.00 (-0.00%)
Volume$550
Capitalization16.62M
INVENTIVA SA
Price$2.28
Change-$1.36 (-37.36%)
Volume$1K
Capitalization460.67M
INNMF vs IVEVF Comparison Chart
Loading...
View a ticker or compare two or three
VS
INNMF vs. IVEVF commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INNMF is a Hold and IVEVF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (INNMF: $0.04 vs. IVEVF: $2.28)
Brand notoriety: INNMF and IVEVF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INNMF: 1% vs. IVEVF: 100%
Market capitalization -- INNMF: $16.62M vs. IVEVF: $460.67M
INNMF [@Biotechnology] is valued at $16.62M. IVEVF’s [@Biotechnology] market capitalization is $460.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INNMF’s FA Score shows that 1 FA rating(s) are green whileIVEVF’s FA Score has 0 green FA rating(s).

  • INNMF’s FA Score: 1 green, 4 red.
  • IVEVF’s FA Score: 0 green, 5 red.
According to our system of comparison, INNMF is a better buy in the long-term than IVEVF.

Price Growth

INNMF (@Biotechnology) experienced а -6.67% price change this week, while IVEVF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
IVEVF($461M) has a higher market cap than INNMF($16.6M). INNMF YTD gains are higher at: -15.254 vs. IVEVF (-37.363).
INNMFIVEVFINNMF / IVEVF
Capitalization16.6M461M4%
EBITDA-6.01MN/A-
Gain YTD-15.254-37.36341%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
INNMF: Fundamental Ratings
INNMF
OUTLOOK RATING
1..100
44
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FSMD41.010.34
+0.84%
Fidelity Small-Mid Multifactor ETF
LQDB84.70N/A
N/A
iShares BBB Rated Corporate Bond ETF
ISHG74.48-0.28
-0.37%
iShares 1-3 Year International TrsBd ETF
EPU48.59-0.20
-0.42%
iShares MSCI Peru ETF
SZK11.79-0.08
-0.70%
ProShares UltraShort Consumer Staples

INNMF and

Correlation & Price change

A.I.dvisor tells us that INNMF and BIVI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNMF and BIVI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNMF
1D Price
Change %
INNMF100%
-10.49%
BIVI - INNMF
26%
Poorly correlated
-0.92%
HOFBF - INNMF
23%
Poorly correlated
N/A
CYTK - INNMF
23%
Poorly correlated
+0.69%
PHRRF - INNMF
20%
Poorly correlated
+3.27%
IVEVF - INNMF
15%
Poorly correlated
N/A
More

IVEVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVEVF has been loosely correlated with VERV. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if IVEVF jumps, then VERV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVEVF
1D Price
Change %
IVEVF100%
N/A
VERV - IVEVF
46%
Loosely correlated
+8.12%
DTIL - IVEVF
32%
Poorly correlated
+7.02%
MIST - IVEVF
28%
Poorly correlated
-0.57%
AWKNF - IVEVF
25%
Poorly correlated
N/A
IDRSF - IVEVF
21%
Poorly correlated
N/A
More